212 related articles for article (PubMed ID: 19840251)
1. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
[TBL] [Abstract][Full Text] [Related]
2. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease.
Trovato GM; Martines GF; Pirri C; Trovato FM; Castro A; Garozzo A; Catalano D
J Clin Gastroenterol; 2012 Jul; 46(6):e46-54. PubMed ID: 22476041
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.
Trovato GM; Martines GF; Trovato FM; Pirri C; Pace P; Garozzo A; Castro A; Catalano D
Dig Dis Sci; 2012 Feb; 57(2):535-44. PubMed ID: 21953137
[TBL] [Abstract][Full Text] [Related]
4. Human obesity relationship with Ad36 adenovirus and insulin resistance.
Trovato GM; Castro A; Tonzuso A; Garozzo A; Martines GF; Pirri C; Trovato F; Catalano D
Int J Obes (Lond); 2009 Dec; 33(12):1402-9. PubMed ID: 19786969
[TBL] [Abstract][Full Text] [Related]
5. Human adenovirus-36 and non-alcoholic fatty liver disease.
Atkinson RL
Liver Int; 2010 Feb; 30(2):164-5. PubMed ID: 20456035
[No Abstract] [Full Text] [Related]
6. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
Hu ZW; Guo JW; Deng XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
[TBL] [Abstract][Full Text] [Related]
7. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and waist circumference in non-alcoholic fatty liver disease.
Rocha R; Cotrim HP; Carvalho FM; Siqueira AC; Braga H; Freitas LA
J Hum Nutr Diet; 2005 Oct; 18(5):365-70. PubMed ID: 16150132
[TBL] [Abstract][Full Text] [Related]
9. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
Eguchi Y; Mizuta T; Ishibashi E; Kitajima Y; Oza N; Nakashita S; Hara M; Iwane S; Takahashi H; Akiyama T; Ario K; Kawaguchi Y; Yasutake T; Iwakiri R; Ozaki I; Hisatomi A; Eguchi T; Ono N; Fujimoto K
Liver Int; 2009 Feb; 29(2):213-20. PubMed ID: 18710430
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
12. ADV36 adipogenic adenovirus in human liver disease.
Trovato FM; Catalano D; Garozzo A; Martines GF; Pirri C; Trovato GM
World J Gastroenterol; 2014 Oct; 20(40):14706-16. PubMed ID: 25356033
[TBL] [Abstract][Full Text] [Related]
13. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
14. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease].
Yang H; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Hong Y
Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):525-8. PubMed ID: 17669243
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus 36 and obesity in children and adolescents.
Gabbert C; Donohue M; Arnold J; Schwimmer JB
Pediatrics; 2010 Oct; 126(4):721-6. PubMed ID: 20855385
[TBL] [Abstract][Full Text] [Related]
17. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Amato MC; Di Marco V; Cammà C; Pizzolanti G; Barcellona MR; Cabibi D; Galluzzo A; Sinagra D; Giordano C; Craxì A
Aliment Pharmacol Ther; 2012 Jan; 35(2):238-47. PubMed ID: 22117531
[TBL] [Abstract][Full Text] [Related]
18. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
19. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
[TBL] [Abstract][Full Text] [Related]
20. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids.
Atkinson RL; Dhurandhar NV; Allison DB; Bowen RL; Israel BA; Albu JB; Augustus AS
Int J Obes (Lond); 2005 Mar; 29(3):281-6. PubMed ID: 15611785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
